skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 407  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page
Refined by: Journal Title: Bmc Cancer remove subject: Male remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study
Material Type:
Article 		Add to My Research

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study

BMC cancer, 2017-05, Vol.17 (1), p.332-332, Article 332 [Peer Reviewed Journal]

COPYRIGHT 2017 BioMed Central Ltd. ;COPYRIGHT 2017 BioMed Central Ltd. ;Copyright BioMed Central 2017 ;The Author(s). 2017 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-017-3286-5 ;PMID: 28511673

Full text available

Citations Cited by
2
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management
Material Type:
Article 		Add to My Research

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

BMC cancer, 2015-10, Vol.15 (1), p.767-767, Article 767 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Smith et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1632-z ;PMID: 26497495

Full text available

Citations Cited by
3
Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer
Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer
Material Type:
Article 		Add to My Research

Controlling nutritional status (CONUT) score as a preoperative risk assessment index for older patients with colorectal cancer

BMC cancer, 2019-11, Vol.19 (1), p.946-946, Article 946 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6218-8 ;PMID: 31690275

Full text available

Citations Cited by
4
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population
Material Type:
Article 		Add to My Research

Depression, anxiety, fatigue, and quality of life in a large sample of patients suffering from head and neck cancer in comparison with the general population

BMC cancer, 2021-01, Vol.21 (1), p.94-94, Article 94 [Peer Reviewed Journal]

COPYRIGHT 2021 BioMed Central Ltd. ;COPYRIGHT 2021 BioMed Central Ltd. ;2021. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07773-6 ;PMID: 33482771

Full text available

Citations Cited by
5
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations
Material Type:
Article 		Add to My Research

Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations

BMC cancer, 2019-06, Vol.19 (1), p.535-535, Article 535 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5756-4 ;PMID: 31159747

Full text available

Citations Cited by
6
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma
Material Type:
Article 		Add to My Research

Tumor infiltrating immune cells (TIICs) as a biomarker for prognosis benefits in patients with osteosarcoma

BMC cancer, 2020-10, Vol.20 (1), p.1022-1022, Article 1022 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07536-3 ;PMID: 33087099

Full text available

Citations Cited by
7
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Transarterial chemoembolization combined with camrelizumab for recurrent hepatocellular carcinoma

BMC cancer, 2022-03, Vol.22 (1), p.270-270, Article 270 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09325-6 ;PMID: 35287627

Full text available

Citations Cited by
8
Artificial intelligence-based prognostic model accurately predicts the survival of patients with diffuse large B-cell lymphomas: analysis of a large cohort in China
Artificial intelligence-based prognostic model accurately predicts the survival of patients with diffuse large B-cell lymphomas: analysis of a large cohort in China
Material Type:
Article 		Add to My Research

Artificial intelligence-based prognostic model accurately predicts the survival of patients with diffuse large B-cell lymphomas: analysis of a large cohort in China

BMC cancer, 2024-05, Vol.24 (1), p.621-621 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12337-z ;PMID: 38773392

Full text available

Citations Cited by
9
Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic
Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic
Material Type:
Article 		Add to My Research

Insights for clinical management from the real-life data of the centralized West of Scotland biliary cancer clinic

BMC cancer, 2024-05, Vol.24 (1), p.597-597 [Peer Reviewed Journal]

2024. The Author(s). ;COPYRIGHT 2024 BioMed Central Ltd. ;The Author(s) 2024 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-024-12279-6 ;PMID: 38755562

Full text available

Citations Cited by
10
INHBA is a prognostic predictor for patients with colon adenocarcinoma
INHBA is a prognostic predictor for patients with colon adenocarcinoma
Material Type:
Article 		Add to My Research

INHBA is a prognostic predictor for patients with colon adenocarcinoma

BMC cancer, 2020-04, Vol.20 (1), p.305-305, Article 305 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06743-2 ;PMID: 32293338

Full text available

Citations Cited by
11
A gene expression-based study on immune cell subtypes and glioma prognosis
A gene expression-based study on immune cell subtypes and glioma prognosis
Material Type:
Article 		Add to My Research

A gene expression-based study on immune cell subtypes and glioma prognosis

BMC cancer, 2019-11, Vol.19 (1), p.1116-1116, Article 1116 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-6324-7 ;PMID: 31729963

Full text available

Citations Cited by
12
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study
Material Type:
Article 		Add to My Research

Postoperative adjuvant treatment strategy for hepatocellular carcinoma with microvascular invasion: a non-randomized interventional clinical study

BMC cancer, 2020-07, Vol.20 (1), p.614-13, Article 614 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07087-7 ;PMID: 32611327

Full text available

Citations Cited by
13
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma
Material Type:
Article 		Add to My Research

Diagnostic and prognostic nomograms for bone metastasis in hepatocellular carcinoma

BMC cancer, 2020-06, Vol.20 (1), p.494-494, Article 494 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-06995-y ;PMID: 32487048

Full text available

Citations Cited by
14
Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience
Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience
Material Type:
Article 		Add to My Research

Do Multidisciplinary Team (MDT) processes influence survival in patients with colorectal cancer? A population-based experience

BMC cancer, 2015-10, Vol.15 (1), p.686-686, Article 686 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Copyright BioMed Central 2015 ;Munro et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1683-1 ;PMID: 26463599

Full text available

Citations Cited by
15
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway
Material Type:
Article 		Add to My Research

microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway

BMC cancer, 2015-06, Vol.15 (1), p.469, Article 469 [Peer Reviewed Journal]

COPYRIGHT 2015 BioMed Central Ltd. ;COPYRIGHT 2015 BioMed Central Ltd. ;Qiao et al. 2015 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-015-1359-x ;PMID: 26077733

Full text available

Citations Cited by
16
The development and validation of the psychological capital questionnaire for patients with Cancer the psychological capital questionnaire
The development and validation of the psychological capital questionnaire for patients with Cancer the psychological capital questionnaire
Material Type:
Article 		Add to My Research

The development and validation of the psychological capital questionnaire for patients with Cancer the psychological capital questionnaire

BMC cancer, 2021-11, Vol.21 (1), p.1194-1194, Article 1194 [Peer Reviewed Journal]

2021. The Author(s). ;COPYRIGHT 2021 BioMed Central Ltd. ;The Author(s) 2021 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-021-08960-9 ;PMID: 34758780

Full text available

Citations Cited by
17
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis
Material Type:
Article 		Add to My Research

The interaction between TERT promoter mutation and MGMT promoter methylation on overall survival of glioma patients: a meta-analysis

BMC cancer, 2020-09, Vol.20 (1), p.897-897, Article 897 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07364-5 ;PMID: 32957941

Full text available

Citations Cited by
18
Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets
Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets
Material Type:
Article 		Add to My Research

Osteoclasts differential-related prognostic biomarker for osteosarcoma based on single cell, bulk cell and gene expression datasets

BMC cancer, 2022-03, Vol.22 (1), p.288-288, Article 288 [Peer Reviewed Journal]

2022. The Author(s). ;COPYRIGHT 2022 BioMed Central Ltd. ;The Author(s) 2022 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-022-09380-z ;PMID: 35300639

Full text available

Citations Cited by
19
The prognostic values of m6A RNA methylation regulators in uveal melanoma
The prognostic values of m6A RNA methylation regulators in uveal melanoma
Material Type:
Article 		Add to My Research

The prognostic values of m6A RNA methylation regulators in uveal melanoma

BMC cancer, 2020-07, Vol.20 (1), p.674-674, Article 674 [Peer Reviewed Journal]

COPYRIGHT 2020 BioMed Central Ltd. ;COPYRIGHT 2020 BioMed Central Ltd. ;2020. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2020 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-020-07159-8 ;PMID: 32682400

Full text available

Citations Cited by
20
Health-related quality of life and utility in head and neck cancer survivors
Health-related quality of life and utility in head and neck cancer survivors
Material Type:
Article 		Add to My Research

Health-related quality of life and utility in head and neck cancer survivors

BMC cancer, 2019-05, Vol.19 (1), p.425-10, Article 425 [Peer Reviewed Journal]

COPYRIGHT 2019 BioMed Central Ltd. ;COPYRIGHT 2019 BioMed Central Ltd. ;2019. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s). 2019 ;ISSN: 1471-2407 ;EISSN: 1471-2407 ;DOI: 10.1186/s12885-019-5614-4 ;PMID: 31064331

Full text available

Citations Cited by

Results 1 - 20 of 407  for All Library Resources

Sorted by: Sorted by: PopularityOr hit Enter to replace sort method
Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
Refine
  1. Before 2013  (33)
  2. 2013 To 2016  (96)
  3. 2017 To 2018  (14)
  4. 2019 To 2021  (215)
  5. After 2021  (49)
  6. More options open sub menu

Subject 

  1. Humans  (406)
  2. Life Sciences & Biomedicine  (394)
  3. Science & Technology  (394)
  4. Oncology  (394)
  5. Female  (375)
  6. Middle Aged  (327)
  7. Aged  (283)
  8. Cancer  (234)
  9. Adult  (220)
  10. Care And Treatment  (216)
  11. Prognosis  (205)
  12. Patients  (193)
  13. Analysis  (190)
  14. Metastasis  (164)
  15. Tumors  (156)
  16. Retrospective Studies  (154)
  17. Health Aspects  (151)
  18. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait